Latest NewsSep 25, 2025HiFiBiO Therapeutics to Present Updated Phase 1 Clinical Data of Two Immuno-Oncology Programs at the 2025 Annual Meeting of the European Society for Medical Oncology (ESMO) All Filter By: Year20252024202320222021202020192018201720162015Apr 7, 2023HiFiBiO Therapeutics Announces Oral Presentation at 2023 American Association for Cancer Research (AACR) Annual MeetingMar 6, 2023Going Global: Insights on the Advantages of Biotech Globalization Published in Drug Discovery Today from HiFiBiO TherapeuticsJan 6, 2023HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200603Life Science Success Podcast | Podcast | Jan 5, 2023HiFiBiO Therapeutics CEO Liang Schweizer Interviewed by Life Science Success PodcastNov 18, 2022HiFiBiO Therapeutics Announces Clinical Trial Supply Agreement to Evaluate HFB200603 in Combination with Tislelizumab in Patients with DIS® Selected Advanced Solid Tumors< 1 … 3 4 5 6 7 … 18 >
